Incidence and Outcomes from Transplant-Associated Thrombotic Microangiopathy in Allogeneic Pediatric Hematopoietic Stem Cell Transplant Recipients before and after the Introduction of Eculizumab: A Single Institution Experience from Oregon Health & Science UniversityKimberly M Lerner, Patrick DeMartino, Evan Shereck et al.|Transplantation and Cellular Therapy|2022Cited by 0